CX-1001

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCX-1001
Drug Alias NameCX-1001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCelentyx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelentyx
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A